
Procyon Corporation – OTC:PCYN
Procyon stock price today
Procyon stock price monthly change
Procyon stock price quarterly change
Procyon stock price yearly change
Procyon key metrics
Market Cap | 1.99M |
Enterprise value | 1.90M |
P/E | -8 |
EV/Sales | 0.40 |
EV/EBITDA | -38.45 |
Price/Sales | 0.41 |
Price/Book | 0.73 |
PEG ratio | 0.06 |
EPS | -0.02 |
Revenue | 4.73M |
EBITDA | -8.48K |
Income | -204.13K |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -4.55% |
Oper. margin | -6.24% |
Gross margin | 74.26% |
EBIT margin | -6.24% |
EBITDA margin | -0.18% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeProcyon stock price history
Procyon stock forecast
Procyon financial statements
Jun 2022 | 1.20M | -79.36K | -6.56% |
---|---|---|---|
Mar 2023 | 1.12M | -29.47K | -2.62% |
Jun 2023 | 1.20M | 7.49K | 0.62% |
Mar 2024 | 1.19M | -102.78K | -8.58% |
Dec 2022 | 3535352 | 895.66K | 25.33% |
---|---|---|---|
Mar 2023 | 3627950 | 1.01M | 28.05% |
Jun 2023 | 3563711 | 946.00K | 26.55% |
Mar 2024 | 3454268 | 1.20M | 34.88% |
Jun 2022 | 10.46K | -22.61K | -37.43K |
---|---|---|---|
Mar 2023 | 39.29K | -279.60K | -40.65K |
Jun 2023 | 157.71K | -151.19K | 120.98K |
Mar 2024 | 58.07K | -748 | 0 |
Procyon alternative data
Aug 2023 | 19 |
---|---|
Sep 2023 | 19 |
Oct 2023 | 19 |
Nov 2023 | 17 |
Dec 2023 | 17 |
Jan 2024 | 17 |
Feb 2024 | 17 |
Mar 2024 | 17 |
Apr 2024 | 17 |
May 2024 | 17 |
Jun 2024 | 17 |
Jul 2024 | 17 |
Procyon other data
Period | Buy | Sel |
---|---|---|
Jun 2024 | 0 | 80000 |
Insider | Compensation |
---|---|
Mr. Justice W. Anderson (1977) Chief Executive Officer, Pres & Director | $277,730 |
Mr. James B. Anderson (1970) Chief Financial Officer & Director | $204,020 |
Mr. George Otis Borak (1961) Vice President of Sales - Amerx Health Care Corporation | $191,030 |
-
What's the price of Procyon stock today?
One share of Procyon stock can currently be purchased for approximately $0.1.
-
When is Procyon's next earnings date?
Unfortunately, Procyon's (PCYN) next earnings date is currently unknown.
-
Does Procyon pay dividends?
No, Procyon does not pay dividends.
-
How much money does Procyon make?
Procyon has a market capitalization of 1.99M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.35% to 4.98M US dollars.
-
What is Procyon's stock symbol?
Procyon Corporation is traded on the OTC under the ticker symbol "PCYN".
-
What is Procyon's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Procyon?
Shares of Procyon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Procyon's key executives?
Procyon's management team includes the following people:
- Mr. Justice W. Anderson Chief Executive Officer, Pres & Director(age: 48, pay: $277,730)
- Mr. James B. Anderson Chief Financial Officer & Director(age: 55, pay: $204,020)
- Mr. George Otis Borak Vice President of Sales - Amerx Health Care Corporation(age: 64, pay: $191,030)
-
How many employees does Procyon have?
As Jul 2024, Procyon employs 17 workers.
-
When Procyon went public?
Procyon Corporation is publicly traded company for more then 28 years since IPO on 11 Dec 1996.
-
What is Procyon's official website?
The official website for Procyon is procyoncorp.com.
-
Where are Procyon's headquarters?
Procyon is headquartered at 1300 South Highland Avenue, Clearwater, FL.
-
How can i contact Procyon?
Procyon's mailing address is 1300 South Highland Avenue, Clearwater, FL and company can be reached via phone at +7 274472998.
Procyon company profile:

Procyon Corporation
procyoncorp.comOTC
19
Drug Manufacturers—Specialty & Generic
Healthcare
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. It provides advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. The company also offers Advantagen, a surgical collagen powder that promotes wound closure and decreases the potential for surgical site infection; and rolled gauze wound care kits. In addition, it provides Bioactive Collagen products in the form of power and matrix under the HELIX3 brand name. Further, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products, as well as retention tapes; and wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name, as well as compression garment line products under the EXTREMIT-EASE brand name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, nursing homes, home health agencies, physicians, and health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. The company was incorporated in 1987 and is based in Oldsmar, Florida.
Clearwater, FL 34677
CIK: 0000812306
ISIN: US7428063009
CUSIP: 742806300